Study S000690

The Effect of the Glucagon Suppressors Pramlintide and Exenatide on Postprandial Glucose Metabolism in Children With Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00950677
Acronym: T2DM
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: COMPLETED
Enrollment: 16
Start: 2009-07
Primary completion: 2011-05
Lead sponsor: Baylor College of Medicine
Conditions: Type 2 Diabetes
Interventions: DRUG:Byetta (exenatide); DRUG:Symlin (pramlintide)
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: NIH:K23DK075931

Registered primary outcomes

Glucose [4 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.